about
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control studyIntradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study.Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.Neurological involvement in primary Sjögren syndrome: a focus on central nervous system.Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial.Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease.Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.MR venography in patients with multiple sclerosis and correlation with clinical and MRI parameters.Efficacy and safety of intravenous immunoglobulin as adjuvant treatment for refractory neuropathic pain. Results of an open-label, multicenter study.Structural brain MR imaging changes associated with obsessive-compulsive disorder in patients with multiple sclerosis.JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.fMRI pain activation in the periaqueductal gray in healthy volunteers during the cold pressor test.From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study
P50
Q34434720-731B1DDF-5DE5-419A-84F5-29022D8C2F88Q36115240-AAFBBFAB-6B04-440E-A539-FF9C6B69DE8DQ36234246-CDE05C02-BCEE-42FB-98E1-5EA6658A8AFCQ37361949-983A92A7-CCA3-4892-843E-3AFE531266F3Q37495729-82EEEA1A-10AF-4108-85DF-95AE4AB9C93AQ38424269-30AF5194-3C4D-4ED9-AA88-B54AD4A7625CQ39618476-E44FBC0D-7244-44F7-924C-64D4AB421BA2Q39686146-0EEF9978-084F-4CCC-9E92-73081DCEE4BFQ43729119-7568B7D2-F5F6-4286-A381-9F1DCB4EA35AQ44003569-34545419-15EC-4F39-8E94-8F1FCBFDBC92Q48390926-B9FFB8C9-E0C6-4850-B0E5-72567143325DQ48431977-D725427D-78B4-4FD1-AEDE-55F3DB59427CQ54230581-2DDAAC3B-773E-4335-A68A-260CA4C7315BQ54327296-DCF84F48-A68B-4635-9B48-23E4C0573EA2Q60859082-DBEA5E3F-3D19-4CA7-A902-6521A9C41D0E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A Francia
@ast
A Francia
@en
A Francia
@es
A Francia
@nl
A Francia
@sl
type
label
A Francia
@ast
A Francia
@en
A Francia
@es
A Francia
@nl
A Francia
@sl
prefLabel
A Francia
@ast
A Francia
@en
A Francia
@es
A Francia
@nl
A Francia
@sl
P106
P31
P496
0000-0002-9550-9082